Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switching to mTOR Inhibitor vs CNI Reduction in BK Nephropathy
NCT01289301Phase 4Unknown
- Sponsor
- Hannover Medical School
- Start
- Oct 2011
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of everolimus in BK virus nephropathy (BKVN), sponsored by Hannover Medical School. Status: unknown.
02
Drugs
everolimus
03
Conditions
BK virus nephropathy (BKVN)
Beyond the preview
Go deeper on NCT01289301.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01289301.